According to a 2024 KFF Health tracking poll, 12 percent of U.S
Discontinuation and weight regain How often people stop the medication TRIUMPH-4 (n=445, 68 weeks, obesity with knee osteoarthritis): 18.2% on 12 mg, 12.2% on 9 mg, 4% on placebo 2 TRANSCEND-T2D-1 (n=537, 40 weeks, type 2 diabetes): 5.1% on 12 mg, 4.5% on 9 mg, 0% on placebo 3 Phase 2 (n=338, 48 weeks): 6 to 16% across doses, 1% on placebo 1 For comparison, Wegovys STEP-1 trial reported a discontinuation rate of around 7% due to side effects, and Mounjaros SURMOUNT-1 reported a similar rate
Bioprotective carnitinoids: lipoic acid, butyrate, and Mitochondria-Targeting to treat radiation injury: mitochondrial drugs come of age
Also the fact that it was confidential is very important
TAM chow causes food avoidance and results in less TAM exposure compared with TAM injection
What was the ambient temperature